Home
BioXcel Therapeutics, Inc. (BTAI) Reaches $8.79 After 6.00% Up Move; Carlisle Companies (CSL) Has 0.72 Sentiment – The FinHeadLines

BioXcel Therapeutics, Inc. (BTAI) Reaches $8.79 After 6.00% Up Move; Carlisle Companies (CSL) Has 0.72 Sentiment – The FinHeadLines

March 1, 2019 No Comments
BioXcel Therapeutics, Inc. (BTAI) Reaches $8.79 After 6.00% Up Move; Carlisle Companies (CSL) Has 0.72 Sentiment  The FinHeadLines

Carlisle Companies Inc (CSL) investors sentiment decreased to 0.72 in 2018 Q3. It's down -0.12, from 0.84 in 2018Q2. The ratio has worsened, as 109 ...

Related Posts

About The Author

SIP Blogger

Leave a Reply

This site uses Akismet to reduce spam. Learn how your comment data is processed.